Md. Imtaiyaz Hassan

Orcid: 0000-0002-3663-4940

According to our database1, Md. Imtaiyaz Hassan authored at least 12 papers between 2011 and 2026.

Collaborative distances:
  • Dijkstra number2 of five.
  • Erdős number3 of five.

Timeline

Legend:

Book  In proceedings  Article  PhD thesis  Dataset  Other 

Links

On csauthors.net:

Bibliography

2026
Structure-based drug repurposing reveals ponatinib and lapatinib as stable inhibitors of Aurora kinase B: Mechanistic insights from high-resolution molecular dynamics and free-energy analyses.
Comput. Biol. Chem., 2026

Phytochemicals as potential AXL inhibitors for cancer therapy: A computational study.
Comput. Biol. Chem., 2026

Next-generation computational strategies for neurodegenerative biomarkers: Multi-omics integration, AI, and molecular modeling.
Comput. Biol. Chem., 2026

2025
Structure-guided discovery of microtubule affinity-regulating kinase 4 inhibitory potential of Harmane: towards therapeutic targeting of Alzheimer's disease.
J. Comput. Aided Mol. Des., December, 2025

Inhibition potential of margolonone and isomargolonone against the dengue virus protease using molecular modeling approaches.
Frontiers Bioinform., 2025

2024
Investigating pH-induced conformational switch in PIM-1: An integrated multi spectroscopic and MD simulation study.
Comput. Biol. Chem., 2024

2021
InstaDock: A single-click graphical user interface for molecular docking-based virtual high-throughput screening.
Briefings Bioinform., 2021

2020
Classification and functional analyses of putative virulence factors of <i>Mycobacterium tuberculosis</i>: A combined sequence and structure based study.
Comput. Biol. Chem., 2020

2019
2/3D-QSAR, molecular docking and MD simulation studies of <i>FtsZ</i> protein targeting benzimidazoles derivatives.
Comput. Biol. Chem., 2019

2016
Functional annotation of putative conserved proteins from Borrelia burgdorferi to find potential drug targets.
Int. J. Comput. Biol. Drug Des., 2016

2015
In silico approaches for the identification of virulence candidates amongst hypothetical proteins of Mycoplasma pneumoniae 309.
Comput. Biol. Chem., 2015

2011
Discovering a potent small molecule inhibitor for gankyrin using de novo drug design approach.
Int. J. Comput. Biol. Drug Des., 2011


  Loading...